N. Tyagarajan V - 01 Feb 2023 Form 4 Insider Report for Genpact LTD (G)

Role
President and CEO, Director
Signature
/s/ Thomas D. Scholtes, as Attorney-in-fact for N.V. Tyagarajan
Issuer symbol
G
Transactions as of
01 Feb 2023
Net transactions value
-$4,203,805
Form type
4
Filing time
03 Feb 2023, 16:15:14 UTC
Previous filing
24 Jan 2023
Next filing
03 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction G Common Shares Options Exercise $967,500 +50,000 +8% $19.35 672,518 01 Feb 2023 Direct
transaction G Common Shares Sale $2,370,940 -50,000 -7.4% $47.42 622,518 01 Feb 2023 Direct F1
transaction G Common Shares Options Exercise $967,500 +50,000 +8% $19.35 672,518 02 Feb 2023 Direct
transaction G Common Shares Sale $2,380,125 -50,000 -7.4% $47.60 622,518 02 Feb 2023 Direct F2
transaction G Common Shares Options Exercise $967,500 +50,000 +8% $19.35 672,518 03 Feb 2023 Direct
transaction G Common Shares Sale $2,355,240 -50,000 -7.4% $47.10 622,518 03 Feb 2023 Direct F3
holding G Common Shares 10,000 01 Feb 2023 By Trust F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction G Employee Stock Option (Right to Buy) Options Exercise $0 -50,000 -5.6% $0.000000 850,000 01 Feb 2023 Common Shares 50,000 $19.35 Direct F5
transaction G Employee Stock Option (Right to Buy) Options Exercise $0 -50,000 -5.9% $0.000000 800,000 02 Feb 2023 Common Shares 50,000 $19.35 Direct F5
transaction G Employee Stock Option (Right to Buy) Options Exercise $0 -50,000 -6.2% $0.000000 750,000 03 Feb 2023 Common Shares 50,000 $19.35 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $47.02 to $47.80. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F2 The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $47.21 to $47.92. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F3 The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $46.83 to $47.47. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F4 These shares are held in trust for the benefit of the reporting person's immediate family members. The reporting person's spouse is one of the trustees of the trust. The reporting person disclaims beneficial ownership of the reported securities held by the trust except to the extent of his pecuniary interest therein.
F5 The option vested 50% on January 10, 2016 and the remainder on January 10, 2018.

Remarks:

The transactions reported on this Form 4 were executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.